South & Central America Brachytherapy Devices Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The South and Central America Brachytherapy Devices Market size is expected to reach US$ 87.0 Million by 2034 from US$ 57.6 Million in 2025. The market is estimated to record a CAGR of 4.9% from 2026 to 2034.

Executive Summary and South and Central America Brachytherapy Devices Market Analysis:

Hospitals and specialized oncology centers across the region are investing in modern brachytherapy systems to provide precise, minimally invasive treatment options that improve patient outcomes and reduce treatment delays.

In Brazil, patients now benefit from improved access to radiotherapy, with treatment initiation times significantly reduced in states such as Acre and Alagoas. Advanced modalities, including intensity-modulated radiotherapy (IMRT), volumetric arc therapy (VMAT), and 3D image-guided radiotherapy, have been integrated alongside brachytherapy to enhance treatment precision and capacity.

In Argentina, cancer is the third leading cause of mortality, with approximately 18% of premature deaths before age 75 attributed to the disease. This growing burden has spurred investments in high-dose-rate (HDR) and image-guided brachytherapy systems, particularly for prostate, cervical, and breast cancers.

Across Colombia, Chile, and Peru, oncology centers are upgrading infrastructure and implementing national programs to expand access to advanced cancer care, strengthen early detection initiatives, and provide precision-guided treatment.

The South America brachytherapy devices market is expanding, driven by rising cancer incidence, regional healthcare modernization, adoption of advanced brachytherapy technologies, and government initiatives aimed at improving access to oncology care across the continent.

South & Central America Brachytherapy Devices Market: Strategic Insights

South and Central America Brachytherapy Devices Market Segmentation Analysis:

• By Product, the South and Central America Brachytherapy Devices Market is segmented into Seeds, Brachytherapy Afterloaders and Applicators, and Electronic Brachytherapy. The Brachytherapy Afterloaders and Applicators segment dominated the market in 2025.
• By Type, the South and Central America Brachytherapy Devices Market is segmented into High Dose Rate Brachytherapy Implants and Low Dose Rate Brachytherapy Implants. The Low Dose Rate Brachytherapy Implants segment dominated the market in 2025.
• By Application, the South and Central America Brachytherapy Devices Market is segmented into Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer, and Others. The Prostate Cancer segment dominated the market in 2025.
• By End-user, the South and Central America Brachytherapy Devices Market is segmented into Hospital and Specialty Clinics, Ambulatory Surgical Centers, and Others. The Hospital and Specialty Clinics segment dominated the market in 2025.

South & Central America Brachytherapy Devices Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Brachytherapy Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

South and Central America Brachytherapy Devices Market Outlook

Access to advanced cancer treatment has historically been limited in many low- and middle-income countries due to infrastructure gaps, equipment shortages, and affordability challenges. Furthermore, the IAEA's September 2025 report revealed that the global disparity in cancer treatment is considerable, especially in the states classified as low-income or middle-income (LMICs), where more than 70% of people do not have access to radiotherapy (RTC) - which is the most important part of a successful cancer treatment plan. The IAEA has established initiatives such as "Rays of Hope" to help with building, expanding and improving the quality of cancer treatment infrastructure in LMICs by providing technical assistance to facilities, workforce training in statistics and other topics, as well as providing assistance with the development of business cases to attract funding to implement national cancer control strategies. The IAEA will also provide support to LMICs with searching for appropriate RTC-related and diagnostic equipment and other necessary items needed for proper cancer treatment.

South and Central America Brachytherapy Devices Market Country Insights

By country, the South and Central America Brachytherapy Devices Market is segmented into Brazil, Argentina, and the Rest of South and Central America. Brazil held the largest share in 2025.

Hospitals and cancer centers are investing in precision-guided and minimally invasive treatment solutions to improve patient outcomes and reduce treatment delays.

In March 2025, patients in the Brazilian state of Acre gained improved access to radiotherapy after the replacement of a defunct cobalt system, allowing treatment initiation within a week instead of traveling over 500 kilometers and facing delays of up to three months. Santa Casa de Misericórdia de Maceió in Alagoas expanded its capabilities beyond its aging linear accelerator to include advanced treatments such as intensity-modulated radiotherapy (IMRT), volumetric arc therapy (VMAT), and 3D image-guided radiotherapy, enhancing treatment volume and complexity.

The growing availability of modern oncology equipment, including brachytherapy systems, and improvements in treatment access are strengthening Brazil's cancer care ecosystem. The brachytherapy devices market in Brazil is growing steadily, driven by technological adoption, healthcare modernization, and initiatives aimed at improving access to high-quality cancer treatment across the country.

South and Central America Brachytherapy Devices Market Company Profiles

Some of the key players operating in the market include Carl Zeiss Meditec, GE HealthCare Technologies Inc, Elekta AB, Siemens Healthineers AG, Becton Dickinson and Co, Eckert & Ziegler AG, Theragenics Corporation, BEBIG Medical, CIVCO Medical Solutions, and C4 Imaging.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South and Central America Brachytherapy Devices Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise